Document is current
Any future updates will be listed below
-
Authors
Indriani, Dwi Wahyu https://orcid.org/0000-0003-0470-5289
Rahmawati, Siti Irma https://orcid.org/0000-0001-5376-7860
Bayu, Asep https://orcid.org/0000-0002-5693-0501
Ahmadi, Peni https://orcid.org/0000-0003-0865-3420
Sari, Anissa Nofita https://orcid.org/0000-0003-3634-8167
Zuraida, Zuraida https://orcid.org/0000-0001-7353-321X
Dharmayanti, Ni Luh Putu Indi https://orcid.org/0000-0002-9399-8193
Putra, Masteria Yunovilsa https://orcid.org/0000-0002-9879-3293
-
Funding
Funding for this research was provided by:
the Research Organization for Health, National Research and Innovation Agency (BRIN), Republic of Indonesia through “Rumah Program Biofarmaseutikal and Biosimilar” 2024 (2/III.9/HK/2024)
the Research Organization for Health, National Research and Innovation Agency (BRIN), Republic of Indonesia through “Rumah Program Biofarmaseutikal and Biosimilar” 2024 (2/III.9/HK/2024)
the Research Organization for Health, National Research and Innovation Agency (BRIN), Republic of Indonesia through “Rumah Program Biofarmaseutikal and Biosimilar” 2024 (2/III.9/HK/2024)
the Research Organization for Health, National Research and Innovation Agency (BRIN), Republic of Indonesia through “Rumah Program Biofarmaseutikal and Biosimilar” 2024 (2/III.9/HK/2024)
- License Information
-
More Information
Article History
Received: 16 November 2024
Accepted: 28 May 2025
First Online: 7 June 2025
Declarations
:
: All experimental procedures, including the treatment of animals, were reviewed and approved by the Ethical Committee on Health of the National Research and Innovation Agency, Republic of Indonesia (053/KE.03/SK/05/2023).
: Not applicable.
: The authors declare no competing interests.
